Kimberlee Leishear, DO | |
745 E Maple Rd, Birmingham, MI 48009-6355 | |
(248) 282-2202 | |
(248) 282-4675 |
Full Name | Kimberlee Leishear |
---|---|
Gender | Female |
Speciality | Physical Medicine & Rehabilitation |
Location | 745 E Maple Rd, Birmingham, Michigan |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1568690600 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | 5101025236 (Michigan) | Primary |
Mailing Address | Practice Location Address |
---|---|
Kimberlee Leishear, DO 745 E Maple Rd, Birmingham, MI 48009-6355 Ph: (248) 282-2202 | Kimberlee Leishear, DO 745 E Maple Rd, Birmingham, MI 48009-6355 Ph: (248) 282-2202 |
News Archive
New research led by SUNY Downstate Medical Center shows that mice devoid of PKMzeta, a molecule previously identified by SUNY Downstate scientists as essential to memory formation and storage, recruit a closely related molecule, PKCiota/lambda, to make up for the missing PKMzeta.
Following its recent introduction of innovative game-based e-learning modules, Pharmaceutical Training International (PTI) is providing the opportunity to make substantial savings on its full range of training courses to start-ups and SMEs (with fewer than 50 employees), as well as non-profit organisations and government bodies...
Genentech, a member of the Roche Group, today announced results from OCEANS, a Phase III study evaluating Avastin (bevacizumab) in combination with chemotherapy followed by the continued use of Avastin alone in women with previously treated (recurrent) platinum-sensitive ovarian cancer.
UT Southwestern Medical Center, seeking to broaden an already robust array of radiation oncology treatments it offers to patients, potentially could play a key role in operating a state-of-the-art proton therapy center for North Texas being planned and funded by San Diego-based Advanced Particle Therapy (APT).
A team of scientists from Sanford Burnham Medical Research Institute has found that the loss of a protein called p62 in the cells and tissue surrounding a tumor can enhance the growth and progression of tumors.
› Verified 1 days ago